HBV and HDV: New Treatments on the Horizon

Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection rep-resent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summa-rized the investigational therapies in the pipeline. Furthermore, we discussed some critical issues such as a “functional cure” approach, the futility of long-term NA therapy and the relevance of understanding drug actions and safety of antivirals, especially in special populations.